scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.YGYNO.2017.07.143 |
P698 | PubMed publication ID | 28800942 |
P50 | author | Adrian Chabowski | Q30902432 |
Lubomir Bodnar | Q87887128 | ||
Agnieszka Blachnio-Zabielska | Q57231066 | ||
Magdalena Świderska | Q63805908 | ||
Pawel Knapp | Q63806411 | ||
P2860 | cites work | Role of Sphingolipids in the Pathobiology of Lung Inflammation | Q26771956 |
Role of sphingolipids in oestrogen signalling in breast cancer cells: an update | Q27025847 | ||
Ceramide 1-phosphate regulates cell migration and invasion of human pancreatic cancer cells | Q30277858 | ||
Plasma membrane targeting by short chain sphingolipids inserted in liposomes improves anti-tumor activity of mitoxantrone in an orthotopic breast carcinoma xenograft model | Q87323848 | ||
Lung injury and lung cancer caused by cigarette smoke-induced oxidative stress: Molecular mechanisms and therapeutic opportunities involving the ceramide-generating machinery and epidermal growth factor receptor. | Q34432733 | ||
The therapeutic potential of modulating the ceramide/sphingomyelin pathway | Q34717833 | ||
Individual profiles of free ceramide species and the constituent ceramide species of sphingomyelin and neutral glycosphingolipid and their alteration according to the sequential changes of environmental oxygen content in human colorectal cancer Caco | Q35059880 | ||
Minireview: human ovarian cancer: biology, current management, and paths to personalizing therapy | Q35872796 | ||
A liquid chromatography/tandem mass spectrometry method for measuring the in vivo incorporation of plasma free fatty acids into intramyocellular ceramides in humans | Q36017612 | ||
Acid ceramidase and human disease | Q36634467 | ||
Plasma sphingolipids and lung cancer: a population-based, nested case-control study | Q37069137 | ||
Sphingolipids in colon cancer | Q37655806 | ||
Sphingolipids in cancer | Q37946727 | ||
Sphingolipids and membrane domains: recent advances. | Q38098403 | ||
Sphingolipids: key regulators of apoptosis and pivotal players in cancer drug resistance | Q38195691 | ||
Ovarian cancer biology and immunotherapy. | Q38218761 | ||
Sphingolipids in the DNA damage response | Q38272799 | ||
Role of Sphingolipids and Metabolizing Enzymes in Hematological Malignancies | Q38495744 | ||
SphK1 promotes tumor cell migration and invasion in colorectal cancer | Q38812061 | ||
Evaluation of the change in sphingolipids in the human multiple myeloma cell line U266 and gastric cancer cell line MGC-803 treated with arsenic trioxide | Q38828943 | ||
Delivery systems of ceramide in targeted cancer therapy: ceramide alone or in combination with other anti-tumor agents | Q38831997 | ||
Differential Regulation of Specific Sphingolipids in Colon Cancer Cells during Staurosporine-Induced Apoptosis | Q40188912 | ||
The effect of the bioactive sphingolipids S1P and C1P on multipotent stromal cells--new opportunities in regenerative medicine | Q40798137 | ||
High levels of sphingolipids in human breast cancer. | Q40964594 | ||
Myocardial infarction differentially alters sphingolipid levels in plasma, erythrocytes and platelets of the rat. | Q41829826 | ||
Sphingolipids modulate the epithelial-mesenchymal transition in cancer. | Q42368079 | ||
Altered sphingolipid metabolism in human endometrial cancer. | Q43131360 | ||
The role of sphingolipids in neuronal plasticity of the brain | Q48825621 | ||
A CERTain role for ceramide in taxane-induced cell death. | Q53547628 | ||
Ceramide: a novel second messenger | Q75292626 | ||
Sphingolipids--who's controlling who in disease? | Q85709979 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | ovarian cancer | Q172341 |
sphingolipids | Q410395 | ||
P304 | page(s) | 139-144 | |
P577 | publication date | 2017-08-08 | |
P1433 | published in | Gynecologic Oncology | Q5625182 |
P1476 | title | Plasma and ovarian tissue sphingolipids profiling in patients with advanced ovarian cancer | |
P478 | volume | 147 |
Q93075146 | Body Mass Index in Multiple Sclerosis modulates ceramide-induced DNA methylation and disease course |
Q52624560 | Identification of Metabolomic Biomarkers for Endometrial Cancer and Its Recurrence after Surgery in Postmenopausal Women. |
Q90273506 | Lipid profile and risk of ovarian tumours: a meta-analysis |
Q57180544 | Ovarian tumours of different histologic type and clinical stage induce similar changes in lipid metabolism |
Q91286832 | Postoperative serum metabolites of patients on a low carbohydrate ketogenic diet after pancreatectomy for pancreatobiliary cancer: a nontargeted metabolomics pilot study |
Q96577395 | Selective detection of phospholipids using molecularly imprinted fluorescent sensory core-shell particles |
Q64898439 | Unique Roles of Sphingolipids in Selected Malignant and Nonmalignant Lesions of Female Reproductive System. |
Search more.